<DOC>
	<DOCNO>NCT02580734</DOCNO>
	<brief_summary>The purpose study determine whether melatonin effective treatment burn mouth syndrome ( BMS ) .</brief_summary>
	<brief_title>Efficacy Melatonin Burning Mouth Syndrome ( BMS )</brief_title>
	<detailed_description>This crossover trial involve total 20 patient Burning Mouth Syndrome , consider chronic neuropathic pain . In two consecutive treatment period , 8 week long , patient receives externally indistinguishable capsule ( placebo melatonin ) . A 4 week wash-out period apply , two period . The capsule contain either placebo 3 mg-melatonin ( 4 time/day total 12 mg/day melatonin ) . The primary endpoint change pain intensity end treatment period , measure use VAS , verbal intensity score NRS , well number oral site affect burn sensation . Furthermore , data quality life , anxiety sleep questionnaire collect ( sf-36 , HAM-A , ESS , MOS ) . Adverse effect carefully record well blood sample , order measure serum melatonin level trial .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Burning Mouth Syndrome</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>patient 18 yr suffer burn mouth syndrome epilepsy pregnancy concomitant treatment melatonin concomitant anticoagulant night time work person</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>burn mouth syndrome</keyword>
	<keyword>treatment</keyword>
	<keyword>oral chronic pain</keyword>
</DOC>